Erasca Jumps on Merck Collaboration for RAS-Mutant Cancer Combo Trial
Erasca rises after teaming with Merck to test ERAS-0015 + Keytruda in RAS cancers, showing early tumor shrink but past safety concern.
/ 1656 items
#XY↓
MoonLake Gets Major Analyst Boost After “Best-in-Class” FDA Meeting
MoonLake gets FDA support for its HS drug, showing top results. Analysts stay bullish with strong growth potential ahead.
Moderna Stock Surges as Hantavirus Vaccine Research Lights Up After Cruise Ship Outbreak
Moderna stock rises as it works on a hantavirus vaccine after a cruise outbreak, but the disease is rare and vaccines will take years.
Replimune Stock Surges After Trump Plans to Fire FDA Chief Marty Makary
Replimune stock jumped after news Trump may fire FDA chief, raising hopes of easier drug approvals despite past rejections.
PTC Therapeutics Beats Wall Street Estimates and Hikes 2026 Outlook on Strong Sephience Launch
PTC beat estimates, Sephience sales surged, losses small, outlook raised, and analysts upgraded stock on strong growth momentum.
Atara Biotherapeutics Stock Soars After FDA Green Light for Cancer Therapy
Atara stock jumps 52% after FDA signals its cancer therapy may get approved, boosting hope for patients and investors.